Prophylaxis of chemotherapy-induced neutropenia with lipegfilgrastim in patients with lung cancer: final results from the non-interventional study NADIR-Reference-Cited by-同舟云学术

Prophylaxis of chemotherapy-induced neutropenia with lipegfilgrastim in patients with lung cancer: final results from the non-interventional study NADIR

Published:2022-09-01 Issue:12 Volume:38 Page:2191-2199
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Geßner Christian¹,Fietz Thomas²,Losem Christoph³,Lück Andreas⁴,Schulz Holger⁵,Niemeier Beate⁶,Groschek Matthias⁷,Eschenburg Henning⁸,Weide Rudolf⁹,Kretzschmar Albrecht¹⁰,Frost Nikolaj¹¹,Hipp Joachim¹²,Harde Johanna⁶,Matillon Christiane D.⁶,Grebhardt Sina⁶,Potthoff Karin⁶

Affiliation:

1. POIS-Leipzig GbR Geßner u. Geßner, Leipzig, Germany

2. Outpatient Center for Hematology, Oncology and Gastroenterology, Singen, Germany

3. Outpatient Center for Hematology and Oncology, Neuss, Germany

4. Outpatient Center for Urology and Oncology, Rostock, Germany

5. Outpatient Center for Internal Oncology and Hematology, Frechen, Germany

6. iOMEDICO, Freiburg im Breisgau, Germany

7. Outpatient Center for Hematology and Oncology, Stolberg, Germany

8. Outpatient Center for Internal Medicine, Hematology and Oncology, Güstrow, Germany

9. Outpatient Center for Hematology and Oncology, Koblenz, Germany

10. Outpatient Center for Internal Medicine, Hematology and Oncology, Leipzig, Germany

11. Department of Infectious Diseases and Pulmonary Medicine, Charité-Universitätsmedizin, Berlin, Germany